Mats Sundgren

ORCID: 0000-0001-5300-5217
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Creativity in Education and Neuroscience
  • Electronic Health Records Systems
  • Management and Organizational Studies
  • Biomedical Text Mining and Ontologies
  • Innovation and Knowledge Management
  • Biotechnology and Related Fields
  • Machine Learning in Healthcare
  • Bioeconomy and Sustainability Development
  • Job Satisfaction and Organizational Behavior
  • Intellectual Capital and Performance Analysis
  • Management Theory and Practice
  • Statistical Methods in Clinical Trials
  • Collaboration in agile enterprises
  • Science, Research, and Medicine
  • Ethics in Clinical Research
  • Complex Systems and Decision Making
  • Pharmaceutical Economics and Policy
  • Academic Writing and Publishing
  • Drug Solubulity and Delivery Systems
  • Motivation and Self-Concept in Sports
  • Data Quality and Management
  • Medical Coding and Health Information
  • Knowledge Management and Sharing
  • Biomedical Ethics and Regulation
  • Quality and Supply Management

AstraZeneca (Sweden)
2007-2023

AstraZeneca (Brazil)
2003-2022

Chalmers University of Technology
2003-2016

AstraZeneca (Singapore)
2003-2016

AstraZeneca (United States)
2014

AstraZeneca (United Kingdom)
2002-2014

A path model of organizational creativity was presented; it conceptualized the influences information sharing, learning culture, motivation, and networking on creative climate. structural equation fitted to data from pharmaceutical industry test proposed model. The accounted for 86% variance in climate-dependent variable. Information sharing had a positive effect which turn climate, while there were negative direct effects climate intrinsic motivation. This study suggests that motivation are...

10.1111/j.1467-9310.2005.00395.x article EN R and D Management 2005-08-31
Dipak Kotecha Folkert W. Asselbergs Stephan Achenbach Stefan D. Anker Dan Atar and 95 more Colin Baigent Amitava Banerjee Birgit Beger Gunnar Brobert Barbara Casadei Cinzia Ceccarelli Martín Cowie Filippo Crea Maureen Cronin Spiros Denaxas Andrea Derix Donna Fitzsimons Martin Fredriksson Chris P Gale Georgios V. Gkoutos Wim Goettsch Harry Hemingway Martin Ingvar Adrian Jonas Robert Kazmierski Susanne Løgstrup R. Thomas Lumbers Thomas F. Lüscher Paul McGreavy Ileana L. Piña Lothar Roessig Carl Steinbeisser Mats Sundgren Benoît Tyl Ghislaine J. M. W. van Thiel Kees van Bochove Panos Vardas Tiago Villanueva Marilena Vrana Wim Weber Franz Weidinger Stephan Windecker Angela Wood Diederick E. Grobbee Xavier Kurz John Concato Robert Kazmierski Jose P. Morales Ileana L. Piña Wim Goettsch Adrian Jonas Niklas Hedberg Filippo Crea Thomas F. Lüscher Wim Weber Tiago Villanueva Stuart Spencer Rupa Sarkar Martin Fredriksson Mats Sundgren Andrea Derix Gunnar Brobert Lothar Roessig Benoît Tyl Kees van Bochove Maureen Cronin Colm Carroll Ceri Thompson Birgit Beger Susanne Løgstrup Marilena Vrana Paul McGreavy Barbara Casadei Stephan Achenbach Valentina Tursini Panos Vardas Dan Atar Colin Baigent Chris P Gale Donna Fitzsimons Stephan Windecker Stefan D. Anker Martín Cowie Amitava Banerjee Harry Hemingway R Tom Lumbers Spiros Denaxas Folkert W. Asselbergs Rick Grobbee Ghislaine J. M. W. van Thiel Dipak Kotecha Georgios V. Gkoutos Angela Wood Martin Ingvar Carl Steinbeisser A. G. Petrova Cinzia Ceccarelli Katija Baljevic Polyxeni Vairami Jennifer Taylor

Big data is central to new developments in global clinical science aiming improve the lives of patients. Technological advances have led routine use structured electronic healthcare records with potential address key gaps evidence. The covid-19 pandemic has demonstrated big and related analytics, but also important pitfalls. Verification, validation, privacy, as well social mandate undertake research are challenges. European Society Cardiology BigData@Heart consortium brought together a...

10.1093/eurheartj/ehac426 article EN cc-by European Heart Journal 2022-08-29

Big data is central to new developments in global clinical science aiming improve the lives of patients. Technological advances have led routine use structured electronic healthcare records with potential address key gaps evidence. The covid-19 pandemic has demonstrated big and related analytics, but also important pitfalls. Verification, validation, privacy, as well social mandate undertake research are challenges. European Society Cardiology BigData@Heart consortium brought together a...

10.1136/bmj-2021-069048 article EN cc-by BMJ 2022-08-29

The European Institute for Innovation through Health Data (i~HD, www.i-hd.eu) has been formed as one of the key sustainable entities arising from Electronic Records Clinical Research (IMI-JU-115189) and SemanticHealthNet (FP7-288408) projects, in collaboration with several other projects initiatives supported by Commission. i~HD is a not-for-profit body, registered Belgium Royal Assent. established to tackle areas challenge successful scaling up innovations that critically rely on...

10.1002/lrh2.10008 article EN cc-by-nc Learning Health Systems 2016-07-25

10.1016/s0731-7085(02)00091-2 article EN Journal of Pharmaceutical and Biomedical Analysis 2002-07-01

Purpose To discuss political entrepreneurship as a capability to enable durable insider action research projects. Design/methodology/approach The two authors utilize auto‐ethnographic methods in order evaluate and draw inferences from their own actions researchers. paper draws on theory theories entrepreneurship. Findings Political is an important factor behind success or failure projects, but has, despite this, been scarcely discussed the literature. indicate that repertoire consisting of...

10.1108/09534810510614913 article EN Journal of Organizational Change Management 2005-10-01

Purpose A dominating view in the literature of organizational creativity is to treat as an ex post facto construct rather than a process that may be subject systematic and thoughtful managerial practices. Drawing on Alfred North Whitehead's writing, paper seeks examine how conceptualized pharmaceutical industry. Design/methodology/approach This study based series interviews with managers scientists three companies. Findings Although researchers designate role most important strategic...

10.1108/14601060710745260 article EN European Journal of Innovation Management 2007-04-20

10.1007/s11213-005-2459-3 article EN Systemic Practice and Action Research 2005-02-01

Regulatory authorities including the Food and Drug Administration European Medicines Agency are encouraging to conduct clinical trials using routinely collected data. The aim of TransFAIR experimental comparison was evaluate, within real-life conditions, ability Electronic Health Records Data Capture (EHR2EDC) module accurately transfer from EHRs EDC systems patients' data studies in various therapeutic areas.

10.1136/bmjhci-2022-100602 article EN cc-by BMJ Health & Care Informatics 2023-06-01

Clinical trial data collection still relies on a manual entry from information available in the medical record. This process introduces delay and error risk. Automating transfer Electronic Health Record (EHR) to Data Capture (EDC) system, under investigators' supervision, would gracefully solve these issues. The present paper describes design of evaluation technology allowing EHR act as eSource for clinical trials. As part EHR2EDC project, 6 ongoing trials, running at 3 hospitals, parallel...

10.3233/shti200184 article EN Studies in health technology and informatics 2020-01-01

Abstract This paper examines management practices and perception related to different change projects at AstraZeneca over a period of five years. The main reason for conducting this study was gain further insight knowledge concerning aspects managing large pharmaceutical organisations. empirical data herein is based on interviews with managers R&D regard involvement in focusing the merger Astra Zeneca. Findings indicate that constitutes good example having two strategies, theories E...

10.1080/14697010500036007 article EN Journal of Change Management 2005-03-01

The knowledge-management literature has been weak on theorising the notion of creativity. This paper is an attempt to conceptualise creativity as series connections in what French philosopher Gilles Deleuze calls a rhizome; horizontal network structure wherein all nodes can be connected one another. argument illustrated by new drug development activities pharmaceutical industry. New drugs are developed four major phases: Discovery (Phase 0) and Development (Phases 1, 2 3). In earlier phases...

10.1504/ijiem.2003.003908 article EN International Journal of Internet and Enterprise Management 2003-01-01

This paper examines how different forms of performance evaluation relate to aspects the creative climate in a major pharmaceutical company. The study was based on large employee‐attitude survey that distributed all company employees. analyses results from 5,333 employees at five R&D sites. indicate management's (either dialogue‐based or control‐based) relates type motivation (intrinsic extrinsic) drives employees, their style thinking (value‐focused thinking) and attitudes organizational...

10.1111/j.1476-8691.2005.00328.x article EN Creativity and Innovation Management 2005-02-25

This paper presents a study of successful and creative projects in the pharmaceutical industry. Creativity is here defined as ability to bring forth new product within specific domain knowledge, namely gastrointestinal, cardiovascular oncological medicine. The paper, being based on interviews with 18 most leading pre‐clinical, clinical researchers at former AB Hässle ICI Pharmaceutical Division, suggests that if creativity be managed an organizational resource, there are least nine facets...

10.1111/1467-8691.00278 article EN Creativity and Innovation Management 2003-09-01
Coming Soon ...